Shannon Eaker
GE Healthcare
8 Papers
86 Citations
Shannon Eaker is an academic researcher from GE Healthcare. The author has contributed to research in topics: Investigational New Drug & Immunotherapy. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
A consensus introduction to serum replacements and serum-free media for cellular therapies
Ohad Karnieli,Oryan Makler Friedner,Julie G. Allickson,Nan Zhang,Sunghoon Jung,D. Fiorentini,Eytan Abraham,Shannon Eaker,tan Kah Yong,Allan Chan,Sarah Griffiths,Amy K. Wehn,Steve Oh +12 more
TL;DR: The paper reviews the available serum replacements, main components, basic strategies for replacement of serum and suggests definitions, where there are no accepted definitions for most of these terms which leads to misleading's and misunderstandings.
177
Concise Review: Guidance in Developing Commercializable Autologous/Patient-Specific Cell Therapy Manufacturing
Shannon Eaker,Myriam Armant,Harvey Brandwein,Scott R. Burger,Andrew Campbell,Carmine Carpenito,Dominic M. Clarke,Timothy Fong,Ohad Karnieli,Knut Niss,Wouter Van't Hof,Ravenska Wagey +11 more
TL;DR: This technical review, members of the International Society for Cell Therapy provide guidance in developing commercializable autologous and patient‐specific manufacturing strategies from the perspective of process development.
64
Regen med therapeutic opportunities for fighting COVID-19.
Anthony Atala,Alicia D. Henn,Martha S. Lundberg,Taby Ahsan,Jordan M. Greenberg,Jeff Krukin,Steven Lynum,Cat Lutz,Kyle J. Cetrulo,Mohammad Z. Albanna,Taciana Pereira,Shannon Eaker,Joshua G. Hunsberger +12 more
TL;DR: Some of the promising regenerative medicine‐based therapies for treating COVID‐19 are critically evaluated and some of the collective technologies and resources that the scientific community currently has available to confront this pandemic are presented.
15
Integrating a 19F MRI Tracer Agent into the Clinical Scale Manufacturing of a T-Cell Immunotherapy.
TL;DR: The ability of 19F MRI to be used in industrial scale applications to visualize the spatial fate of cellular therapeutics is demonstrated, using state-of-the-art methods and equipment in the manufacture of a cellular therapy.
Bioreactor Technology for Cell Therapy Manufacturing in Regenerative Medicine
Hu Zhang,David E. Kent,Mohammad Z. Albanna,Lexan Lhu,Xiuzhi Susan Sun,Shannon Eaker,Sita Somara +6 more
TL;DR: In this article, a review of commercially available bioreactors and their applications for regenerative therapeutic products is presented. And regulatory, quality, and manufacturing aspects of these bi-actors are discussed.
7